Item 3. Legal Proceedings
Item
3.
Legal
Proceedings.
The
Company is subject to various legal proceedings arising from normal business operations. Although there can be no assurances, based on
the information currently available, management believes that it is probable that the ultimate outcome of each of the actions will not
have a material adverse effect on the consolidated financial statement of the Company. However, an adverse outcome in certain of the
actions could have a material adverse effect on the financial results of the Company in the period in which it is recorded.
Axon
The
Company owns U.S. Patent No. 9,253,452 (the “‘452 Patent’”), which generally covers the automatic activation
and coordination of multiple recording devices in response to a triggering event, such as a law enforcement officer activating the light
bar on the vehicle.
11
The
Company filed suit on January 15, 2016 in the U.S. District Court for the District of Kansas (Case No: 2:16-cv-02032) against Axon, alleging
wilful patent infringement against Axon’s body camera product line and Signal auto-activation product. The Company is seeking
both monetary damages and a permanent injunction against Axon for infringement of the ‘452 Patent.
In
December 2016 and January 2017, Axon filed two petitions for Inter Partes Review (“IPR”) against the ‘452 Patent.
The USPTO rejected both of Axon’s petitions. Axon is now statutorily precluded from filing any more IPR petitions against the ‘452
Patent.
The
District Court litigation in Kansas was temporarily stayed following the filing of the petitions for IPR. However, on November 17, 2017,
the Federal District Court of Kansas rejected Axon’s request to maintain the stay. With this significant ruling, the parties will
now proceed towards trial. Since litigation has resumed, the Court has issued a claim construction order (also called a Markman Order)
where it sided with the Company on all disputes and denied Axon’s attempts to limit the scope of the claims. Following the Markman
Order, the Court set all remaining deadlines in the case. Fact discovery closed on October 8, 2018, and a Final Pretrial Conference
took place on January 16, 2019. The parties filed motions for summary judgment on January 31, 2019.
On
June 17, 2019, the Court granted Axon’s motion for summary judgment that Axon did not infringe on the Company’s patent and
dismissed the case. Importantly, the Court’s ruling did not find that Digital’s ‘452 Patent was invalid. It also did
not address any other issue, such as whether Digital’s requested damages were appropriate, and it did not impact the Company’s
ability to file additional lawsuits to hold other competitors accountable for patent infringement. This ruling solely related to an interpretation
of the claims as they relate to Axon and was unrelated to the supplemental briefing Digital recently filed on its damages claim and the
WatchGuard settlement. Those issues are separate and the judge’s ruling on summary judgment had nothing to do with Digital’s
damages request.
The
Company filed an opening appeal brief on August 26, 2019 with the U.S. Court of Appeals for the Tenth Circuit (the “Court of Appeals”),
appealing the U.S. District Court’s granting of Axon’s motion for summary judgment. Axon responded by filing a responsive
brief on November 6, 2019 and we then filed a reply brief responding to Axon on November 27, 2019. The Court of Appeals scheduled oral
arguments on our appeal of the U.S. District Court’s summary judgment ruling on April 15, 2020. This appeal was intended
to address the Company’s position that the U.S. District Court incorrectly dismissed our claims against Axon. If the Court of Appeals
overturns the ruling of the U.S. District Court, the case will be remanded to the U.S District Court before a new judge. On March 12,
2020, the panel of judges for the Court of Appeals issued an order cancelling the oral arguments previously set for April 15,
2020, having determined that the appeal will be decided solely based on the parties’ briefs. On April 22, 2020, a three-judge panel
of the United States Court of Appeals denied our appeal and affirmed the District Court’s previous decision to grant Axon summary
judgment. On May 22, 2020, we filed a petition for panel rehearing requesting that we be granted a rehearing of our appeal of the U.S.
District Court’s summary judgment ruling. Furthermore, we filed a motion requesting that we be given an opportunity to make our
case through oral argument in front of the three-judge panel of the Court of Appeals, which motion was denied on June 9, 2020. The Company
had until November 7, 2020 to decide whether it would appeal the U.S. District Court’s and Court of Appeals’ decisions to
the United States Supreme Court. The Company has abandoned its right to any further appeals.
General
From
time to time, we are notified that we may be a party to a lawsuit or that a claim is being made against us. It is our policy to not disclose
the specifics of any claim or threatened lawsuit until the summons and complaint are actually served on us. After carefully assessing
the claim, and assuming we determine that we are not at fault or we disagree with the damages or relief demanded, we vigorously defend
any lawsuit filed against us. We record a liability when losses are deemed probable and reasonably estimable. When losses are deemed
reasonably possible but not probable, we determine whether it is possible to provide an estimate of the amount of the loss or range of
possible losses for the claim, if material for disclosure. In evaluating matters for accrual and disclosure purposes, we take into consideration
factors such as our historical experience with matters of a similar nature, the specific facts and circumstances asserted, the likelihood
of our prevailing, the availability of insurance, and the severity of any potential loss. We reevaluate and update accruals as matters
progress over time.
While
the ultimate resolution is unknown, we do not expect that these lawsuits will individually, or in the aggregate, have a material adverse
effect to our results of operations, financial condition or cash flows. However, the outcome of any litigation is inherently uncertain
and there can be no assurance that any expense, liability or damages that may ultimately result from the resolution of these matters
will be covered by our insurance or will not be in excess of amounts recognized or provided by insurance coverage and will not have a
material adverse effect on our operating results, financial condition or cash flows.
Item
4.
Mine
Safety Disclosures.
Not
applicable.
12
PART
II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.